Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2011

View Archived Issues

Novel orexin receptor antagonists described by Merck & Co.

New free fatty acid FFA1 receptor agonists disclosed

Phase IIa study shows no appreciable difference between SYN-118 and placebo in Parkinson's disease

Genasense does not improve survival of dacarbazine-treated patients with melanoma in phase III trial

SLC23A1 gene SNP correlates with neovascular age-related macular degeneration

AZD-3199 has long-lasting bronchoprotective activity in vivo

Scientists identify alpha-1-antitrypsin as marker of cutaneous squamous cell carcinoma progression

Gene therapy JVS-100 is safe in patients with heart failure after myocardial infarction

Pfizer designs new sodium/glucose cotransporter 2 inhibitors

Anavex advances Alzheimer's disease candidate ANAVEX 2-73 to higher dose in phase I trial

Lilly forms new critical care company BioCritica

Mutations in CACNA2D1 gene may confer susceptibility to Brugada syndrome

Provectus Pharmaceuticals completes accrual in phase IIc PH-10 trial in psoriasis

Ampio Pharmaceuticals completes evaluation of phase III data on Zertane

Merck & Co. presents new NO-linked cicletanine and derivatives

NovaBay's NVC-422 shows promise in patients with epidemic keratoconjunctivitis

Novel erythropoietin production enhancers presented by Daiichi Sankyo

Prometheus to be acquired by Nestle Health Science

Preclinical study of Proteonomix's UMK-121 suggests ability to mobilize stromal stem cells

Toxicology studies completed for Alzheimer's disease drug candidate SUVN-502

FDA sets PDUFA date for fentanyl sublingual spray NDA review

FDA advisory committee to discuss Regeneron's BLA for VEGF Trap-Eye in June

Basilea Pharmaceutica reports topline data from first phase I trial of BAL-30072

Eisai and University College London to conduct joint research in neurodegenerative disease

CHMP issues negative trend vote on Bronchitol for cystic fibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...